| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1995;26:1922-1929.)
© 1995 American Heart Association, Inc.
Articles |
Structure and Function of the Rat Basilar Artery During Chronic Nitric Oxide Synthase Inhibition
From the Departments of Cardiology, Cardiovascular Research (P.M., H.T., C.F.K., T.F.L.), and Pathology (M.-M. van R., T.S.), University Hospital, Bern, Switzerland.
Correspondence to Thomas F. Lüscher, MD, Cardiology, University Hospital, CH-3010 Bern, Switzerland.
Background and Purpose Nitric oxide is an important regulator of vascular tone and may also be implicated in the modulation of vascular growth and structure. This study presents the effects of chronic nitric oxide inhibition, with or without antihypertensive treatment, on the structure and function of the basilar artery in rats.
Methods Rats were treated for 6 weeks with
N
-nitro-L-arginine methyl ester
(50 mg/kg per day) alone or in combination with verapamil
(100 mg/kg per day) or with trandolapril (1 mg/kg per day). Untreated
rats served as controls. The structure and reactivity of perfused and
pressurized basilar arteries were analyzed in vitro using a
video dimension analyzer.
Results Systolic arterial pressure increased only in the nitro-arginine–treated group, as did the media-to-lumen ratio of the basilar artery. This structural alteration, which was prevented by verapamil and trandolapril, was mainly due to remodeling and not to growth. Chronic inhibition of the L-arginine pathway increased the response of the basilar artery to serotonin, while the opposite was found for endothelin. Verapamil and trandolapril prevented these functional alterations that seemed related to the changes in the vascular structure.
Conclusions The remodeling and functional alterations of the basilar artery seem to depend mainly on the elevation of arterial pressure with little contribution of the L-arginine pathway. Furthermore, nitric oxide does not seem to be implicated in the modulation of normal cerebral vascular growth in vivo. However, hypertension-induced changes in vascular reactivity and structure could alter cerebral blood flow and eventually contribute to the development of stroke in this model of hypertension.
Key Words: antihypertensive therapy • basilar artery • endothelium, vascular • Hypertension • nitric oxide • rats
This article has been cited by other articles:
 |
|
 |
|
  M. J. Cipolla, J. Smith, N. Bishop, L. V. Bullinger, and J. A. Godfrey Pregnancy Reverses Hypertensive Remodeling of Cerebral Arteries Hypertension, April 1, 2008; 51(4): 1052 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cipolla Cerebrovascular Function in Pregnancy and Eclampsia Hypertension, July 1, 2007; 50(1): 14 - 24. [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Ingram, S. C. Newcomer, E. M. Price, K. E. Eklund, R. M. McAllister, and M. H. Laughlin Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arterioles Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2798 - H2808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cipolla, N. DeLance, and L. Vitullo Pregnancy Prevents Hypertensive Remodeling of Cerebral Arteries: A Potential Role in the Development of Eclampsia Hypertension, March 1, 2006; 47(3): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M.A.C. Martens, B. Demeilliers, D. Girardot, C. Daigle, H. H. Dao, D. deBlois, and P. Moreau Vessel-Specific Stimulation of Protein Synthesis by Nitric Oxide Synthase Inhibition: Role of Extracellular Signal-Regulated Kinases 1/2 Hypertension, January 1, 2002; 39(1): 16 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang, A. Madinova, T. Kozai, H. Joch, U. Aebi, and T. F Luscher Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth Cardiovasc Res, January 1, 2002; 53(1): 227 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Saavedra, T. Ito, and Y. Nishimura Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S102 - S109. [PDF]
|
|
|
|
 |
|
 D. L. Ceiler and J. G. R. De Mey Chronic NG-Nitro-L-Arginine Methyl Ester Treatment Does Not Prevent Flow-Induced Remodeling in Mesenteric Feed Arteries and Arcading Arterioles Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2057 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moreau Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res, September 1, 1998; 39(3): 534 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moreau, H. Takase, L. V. d'Uscio, T. F. Luscher, and G. L. Baumbach Effect of Chronic Nitric Oxide Deficiency on Angiotensin II–Induced Hypertrophy of Rat Basilar Artery • Editorial Comment Stroke, May 1, 1998; 29(5): 1031 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moreau, L. V d'Uscio, and T. F Luscher Structure and reactivity of small arteries in aging Cardiovasc Res, January 1, 1998; 37(1): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. d'Uscio, M. Barton, S. Shaw, P. Moreau, and T. F. Luscher Structure and Function of Small Arteries in Salt-Induced Hypertension : Effects of Chronic Endothelin-Subtype-A–Receptor Blockade Hypertension, October 1, 1997; 30(4): 905 - 911. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Moreau, L. V. d'Uscio, S. Shaw, H. Takase, M. Barton, and T. F. Luscher Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy : Reversal by ETA-Receptor Antagonist Circulation, September 2, 1997; 96(5): 1593 - 1597. [Abstract] [Full Text]
|
|
|
|
|
|
P. Moreau, H. Takase, C. F. Kung, S. Shaw, and T. F. Luscher Blood Pressure and Vascular Effects of Endothelin Blockade in Chronic Nitric Oxide–Deficient Hypertension Hypertension, March 1, 1997; 29(3): 763 - 769. [Abstract] [Full Text]
|
|